leisure time -WSS

leisure time

author：explore 2025-09-29 16:35:53 - browse：1

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： BioAge raises $170M for combination therapy with Zepbound

hotspot

WSS

Bird flu outbreak in cows is latest avian flu curveball

Q&A: Jennifer Adair on making gene therapy available globally

FTC falls short on scrutinizing hospital mergers, study says

Getting Alzheimer's drug Leqembi to patients can be a challenge

H5N1 bird flu found in pasteurized milk: what we know

H5N1 bird flu virus started spreading in cows in Texas in December

leisure time

leisure time

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Medical mystery: When a cough is not just a cough

In age of alternative facts, a scholarly course on calling out crap

What should King Charles tell the public about his cancer?

Cancer drug shortages should be causing more outrage

Getting Alzheimer's drug Leqembi to patients can be a challenge

The high cost of giving birth even with insurance

Q&A: Jennifer Adair on making gene therapy available globally

New air purifier tech could be key to improving indoor air quality

MultiPlan and major insurers sued for alleged medical price

explore

A disappointing year of Humira biosimilars

'Revelatory' study finds a smoking impact that remains after quitting

Robert F. Kennedy is pitching centrism on health, even on abortion

Key House Republican on health care plans exit from Congress

For Medicare Advantage, Democrats want stronger protections around AI

BioAge raises $170M for combination therapy with Zepbound

hotspot

leisure time

focus

focus